BOSTON–(BUSINESS WIRE)–Aura Biosciences Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing a novel class of virus-like drug conjugate (VDC) therapies for multiple oncology indications, today announced that Elisabet de los Pinos, P…
Author: Business Wire
Sunvera Group Announces Partnership with Castleman Eye Center
BINGHAM FARMS, Mich.–(BUSINESS WIRE)–Sunvera Group forms a new partnership with Castleman Eye Center, expanding their network in the Metro Detroit market.
Novaliq prévoit de déposer une demande d’autorisation de mise sur le marché de l’UE du CyclASol® pour le traitement de la sécheresse oculaire en juillet 2023
HEIDELBERG (Allemagne) et CAMBRIDGE (Massachusetts), États-Unis–(BUSINESS WIRE)–Novaliq, une société biopharmaceutique spécialisée dans les thérapies oculaires de pointe basées sur la technologie exclusive sans eau EyeSol®, a annoncé aujourd’hui son …
Novaliq planea solicitar la autorización de comercialización de CyclASol® en la UE para el tratamiento de la queratoconjuntivitis en julio 2023
HEIDELBERG, Alemania y CAMBRIDGE, Massachusetts, EE.UU.–(BUSINESS WIRE)–Novaliq, una compañía biofarmacéutica que concentra los mejores terapéuticos oculares basados en la tecnología única y water-free de EyeSol,® ha anunciado hoy sus planes para sol…
Novaliq intende depositare a luglio del 2023 una richiesta di autorizzazione all'immissione in commercio nell'UE di CyclASol® per il trattamento della sindrome dell'occhio secco
HEIDELBERG, Germania e CAMBRIDGE, Massachussets, USA–(BUSINESS WIRE)–Novaliq, un’azienda biofarmaceutica che si dedica allo sviluppo di terapie oculari della massima qualità basate sull’esclusiva tecnologia senz’acqua EyeSol®, ha annunciato oggi la s…
Novaliq is van plan in juli 2023 een handelsvergunning aan te vragen voor CyclASol® in de EU voor de behandeling van droge-ogenziekte
HEIDELBERG, Duitsland & CAMBRIDGE, MA, VS–(BUSINESS WIRE)–Novaliq, een biofarmaceutisch bedrijf dat zich richt op eersteklas en best-in-class oculaire therapieën op basis van de unieke watervrije EyeSol®-technologie, kondigde vandaag aan dat het van …
Novaliq plant, im Juli 2023 einen Antrag auf Marktzulassung für CyclASol® zur Behandlung des Syndroms des trockenen Auges in der EU zu stellen
HEIDELBERG, Deutschland & CAMBRIDGE, Massachusetts, USA–(BUSINESS WIRE)–Novaliq, ein biopharmazeutisches Unternehmen, das sich auf erste und beste Augentherapeutika konzentriert, die auf der einzigartigen wasserfreien EyeSol®-Technologie basieren, ga…
Study Shows Novel Flavoprotein Fluorescence Measure is Correlated with Age-Related Macular Degeneration (AMD) Stage
ANN ARBOR, Mich.–(BUSINESS WIRE)–OcuSciences, a medical device company developing ocular imagers to detect early disease by assessing retinal metabolic activity, today announced the publication of an Age-related Macular Degeneration (AMD) study in th…
Novaliq Plans to File a Markting Authorisation Application for CyclASol® in the E.U. for the Treatment of Dry Eye Disease in July 2023
HEIDELBERG, Germany & CAMBRIDGE, MA, USA–(BUSINESS WIRE)– #EMA–Novaliq, a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics based on the unique EyeSol® water-free technology, today announced its plans for filing a Ma…
World Dry Eye Syndrome Market Size, Share and Trends Analysis Report 2022-2027 – Increasing Research & Development and Promising Pipeline Products – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Dry Eye Syndrome Market Size, Share and Trends Analysis by Region, Product, Therapy Area, Distribution Channel and Segment Forecast, 2022-2027” report has been added to ResearchAndMarkets.com’s offering. The dry eye syndro…
The Worldwide Therapeutic Contact Lenses Industry is Expected to Reach $4.2 Billion by 2027: Public and Private Initiatives to Increase Vision Care Awareness Drives Growth – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Therapeutic Contact Lenses Market – Global Outlook & Forecast 2022-2027” report has been added to ResearchAndMarkets.com’s offering. The global therapeutic contact lenses market is expected to grow at a CAGR of 4.90% f…
Warby Parker to Announce Fourth Quarter and Full Year 2022 Financial Results on February 28, 2023
NEW YORK–(BUSINESS WIRE)–Warby Parker Inc. (NYSE: WRBY) (the “Company”), a direct-to-consumer lifestyle brand focused on vision for all, today announced that its financial results for the fourth quarter and full year ended December 31, 2022, will be …
STAAR Surgical to Report Fourth Quarter and Fiscal Year Results on February 21, 2023
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that it will release financial results for the…
New Bausch + Lomb Social Media Campaign Highlights What ‘Sights’ Inspire AMD Patients
VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb”), a leading global eye health company dedicated to helping people see better to live better, today announced a new social media campaign designed to raise aw…
Aldeyra Therapeutics Announces FDA Acceptance of New Drug Application for Reproxalap for the Treatment of Dry Eye Disease
LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced that the U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for topical ocular reproxalap, a first-in-class investig…
NovaBay Pharmaceuticals Chief Product Officer Dr. Audrey Kunin to Discuss DERMAdoctor’s Eczema Treatment on Two QVC® Shows on February 7
EMERYVILLE, Calif.–(BUSINESS WIRE)—- $NBY #Avenova–NovaBay announces DERMAdoctor’s Eczema Treatment to be featured on Two QVC® Shows on February 7
Tracey Technologies Announces New Features with Version 7.0 Upgrade
HOUSTON–(BUSINESS WIRE)–Tracey Technologies announced the release of iTrace Prime, an upgraded software for the iTrace Ray Tracing Aberrometer and Corneal Topographer from a trusted leader in ophthalmic technology development. This new software versi…
Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PARSIPPANY, N.J.–(BUSINESS WIRE)–Iveric Bio granted equity-based awards pursuant to the Company’s 2019 Inducement Stock Incentive Plan to 16 newly-hired, non-executive employees.
Guide Dogs for the Blind Partners With American Printing House for the Blind to Aid Careers of Young People
SAN RAFAEL, Calif.–(BUSINESS WIRE)–Guide Dogs for the Blind (GDB) and American Printing House for the Blind (APH) ConnectCenter have announced a partnership to offer joint programming and career development programs for young adults who are blind or …
Alcon Canada lance aujourd’hui les nouvelles lentilles cornéennes TOTAL pour les patients atteints d’astigmatisme
TORONTO–(BUSINESS WIRE)–Alcon (SIX/NYSE : ALC), le chef de file mondial des soins oculaires dont la mission est d’aider les gens à voir avec clarté, a annoncé aujourd’hui le lancement au Canada de TOTAL30MD pour l’astigmatisme et DAILIES TOTAL1MD pou…